Revolution Medicines, Inc. (RVMD)
NASDAQ: RVMD · Real-Time Price · USD
81.49
+1.64 (2.05%)
Jan 7, 2026, 11:29 AM EST - Market open
Revolution Medicines Market Cap
Revolution Medicines has a market cap or net worth of $15.75 billion as of January 7, 2026. Its market cap has increased by 88.76% in one year.
Market Cap
15.75B
Enterprise Value
14.14B
1-Year Change
88.76%
Ranking
Category
Stock Price
$81.49
Market Cap Chart
Since February 13, 2020, Revolution Medicines's market cap has increased from $1.64B to $15.75B, an increase of 857.91%. That is a compound annual growth rate of 46.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 5, 2026 | 15.14B | -1.66% |
| Dec 31, 2025 | 15.40B | 90.50% |
| Dec 31, 2024 | 8.08B | 71.26% |
| Dec 29, 2023 | 4.72B | 123.15% |
| Dec 30, 2022 | 2.11B | 14.03% |
| Dec 31, 2021 | 1.85B | -29.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Feb 13, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 932.55B |
| Johnson & Johnson | 492.24B |
| AbbVie | 389.14B |
| UnitedHealth Group | 309.81B |
| AstraZeneca | 280.48B |
| Merck & Co. | 266.67B |
| Novartis AG | 262.61B |
| Novo Nordisk | 241.55B |